A353190 Stock Overview
Researches, develops, manufactures, and distributes health supplements in South Korea and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 1/6 |
Past Performance | 3/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Hurum Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩1,122.00 |
52 Week High | ₩1,423.00 |
52 Week Low | ₩970.00 |
Beta | 0.63 |
11 Month Change | 7.37% |
3 Month Change | 6.15% |
1 Year Change | -17.92% |
33 Year Change | -62.91% |
5 Year Change | n/a |
Change since IPO | -44.04% |
Recent News & Updates
Shareholder Returns
A353190 | KR Personal Products | KR Market | |
---|---|---|---|
7D | -0.09% | -4.1% | 0.02% |
1Y | -17.9% | 25.0% | 5.7% |
Return vs Industry: A353190 underperformed the KR Personal Products industry which returned 25% over the past year.
Return vs Market: A353190 underperformed the KR Market which returned 5.7% over the past year.
Price Volatility
A353190 volatility | |
---|---|
A353190 Average Weekly Movement | 5.5% |
Personal Products Industry Average Movement | 7.2% |
Market Average Movement | 5.0% |
10% most volatile stocks in KR Market | 11.2% |
10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A353190 has not had significant price volatility in the past 3 months.
Volatility Over Time: A353190's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2005 | 134 | Jin Seok Kim | hurumcorp.com |
Hurum Co., Ltd. researches, develops, manufactures, and distributes health supplements in South Korea and internationally. The company offers lactobacillus under the TrueLAC brand name; and yogurt and biological health supplements. It also operates frozen yogurt franchise store under the Yogurberry name.
Hurum Co., Ltd. Fundamentals Summary
A353190 fundamental statistics | |
---|---|
Market cap | ₩44.18b |
Earnings (TTM) | ₩2.73b |
Revenue (TTM) | ₩94.66b |
16.2x
P/E Ratio0.5x
P/S RatioIs A353190 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A353190 income statement (TTM) | |
---|---|
Revenue | ₩94.66b |
Cost of Revenue | ₩59.63b |
Gross Profit | ₩35.02b |
Other Expenses | ₩32.29b |
Earnings | ₩2.73b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 69.41 |
Gross Margin | 37.00% |
Net Profit Margin | 2.89% |
Debt/Equity Ratio | 37.1% |
How did A353190 perform over the long term?
See historical performance and comparison